New pharmacogenetic test for detecting an HLA-A*31:01 allele using the InvaderPlus assay

Pharmacogenetics and Genomics

Volumn 22, Issue 6, 2012, Pages 441-446

  Aoki, Masayuki ^a   Hosono, Naoya ^a   Takata, Sadaaki ^a   Nakamura, Yusuke ^b   Kamatani, Naoyuki ^a   Kubo, Michiaki ^a  

^a RIKEN   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

HLA A*31:01; InvaderPlus; Pharmacogenetic test; Sequence specific primer PCR

Indexed keywords

CARBAMAZEPINE; HLA A ANTIGEN;

ADVERSE DRUG REACTION; AFRICAN AMERICAN; ALLELE; ARTICLE; ASIAN; EUROPEAN AMERICAN; GENOTYPING TECHNIQUE; HAPLOTYPE MAP; HUMAN; JAPANESE; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84861192110     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3283527c40     Document Type: Article

References (20)

1. Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005; 209:123-129.
2. Chung WH, Hung SI, Chen YT. Human leukocyte antigens and drug hypersensitivity. Curr Opin Allergy Clin Immunol 2007; 4:317-323.
3. Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004; 428:486.
4. Ozeki T, Mushiroda T, Yowang A, Takahashi A, Kubo M, Shirakata Y, et al. Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population. Hum Mol Genet 2011; 20:1034-1041.
5. McCormack M, Alfirevic A, Bourgeois S, Farrell JJ, Kasperavičiute D, Carrington M, et al. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med 2011; 3641: 1134-1143.
6. Adams SD, Barracchini KC, Simonis TB, Stroncek D, Marincola FM. High throughput HLA sequence-based typing (SBT) utilizing the ABI Prism 3700 DNA Analyzer. Tumori 2001; 87:S40-S43. (Pubitemid 32861883)
7. Itoh Y, Mizuki N, Shimada T, Azuma F, Itakura M, Kashiwase K, et al. High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCRSSOP- Luminex method in the Japanese population. Immunogenetics 2005; 57:717-729. (Pubitemid 41598618)
8. Faner R, Casamitjana N, Coll J, Caro P, Pujol-Borrell R, Palou E, et al. Realtime PCR using fluorescent resonance emission transfer probes for HLA-B typing. Hum Immunol 2006; 67:374-385. (Pubitemid 44250960)
9. Erlich RL, Jia X, Anderson S, Banks E, Gao X, Carrington M, et al. Nextgeneration sequencing for HLA typing of class I loci. BMC Genomics 2011; 12:42.
10. Lind C, Ferriola D, Mackiewicz K, Heron S, Rogers M, Slavich L, et al. Nextgeneration sequencing: the solution for high-resolution, unambiguous human leukocyte antigen typing. Hum Immunol 2010; 71:1033-1042.
11. Gabriel C, Danzer M, Hackl C, Kopal G, Hufnagl P, Hofer K, et al. Rapid high-throughput human leukocyte antigen typing by massively parallel pyrosequencing for high-resolution allele identification. Hum Immunol 2009; 70:960-964.
12. Hosono N, Chantarangsu S, Kiyotani K, Takata S, Tsuchiya Y, Mahasirimongkol S, et al. Development of new HLA-B*3505 genotyping method using Invader assay. Pharmacogenet Genomics 2010; 20: 630-633.
13. Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe'er I, Floratos A, et al. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 2009; 41:816-819.
14. Singer JB, Lewitzky S, Leroy E, Yang F, Zhao X, Klickstein L, et al. A genomewide study identifies HLA alleles associated with lumiracoxib-related liver injury. Nat Genet 2010; 42:711-714.
15. Spraggs CF, Budde LR, Briley LP, Bing N, Cox CJ, King KS, et al. HLADQA1* 02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer. J Clin Oncol 2011; 29:667-673.
16. Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 2011; 39:D913-D919.
17. Hwang SH, Oh HB, Hur SS, Lee MN, Hong SA, Kwon OJ. Novel HLA-A*31 allele, A*3111 identified by sequence-based typing. Tissue Antigens 2005; 66:145-147.
18. Ghosh SS, Eis PS, Blumeyer K, Fearon K, Millar DP. Real time kinetics of restriction endonuclease cleavage monitored by fluorescence resonance energy transfer. Nucleic Acids Res 1994; 22:3155-3159. (Pubitemid 24260650)
19. Lyamichev V, Mast AL, Hall JG, Prudent JR, Kaiser MW, Takova T, et al. Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nat Biotechnol 1999; 17:292-296. (Pubitemid 29122638)
20. Ohnishi Y, Tanaka T, Ozaki K, Yamada R, Suzuki H, Nakamura Y. A highthroughput SNP typing system for genome-wide association studies. J Hum Genet 2001; 46:471-477. (Pubitemid 32744120)